tiprankstipranks
Trending News
More News >
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market

Sunshine Biopharma (SBFM) Financial Statements

Compare
426 Followers

Sunshine Biopharma Financial Overview

Sunshine Biopharma's market cap is currently $6.72M. The company's EPS TTM is $-0.19; its P/E ratio is -0.74; Sunshine Biopharma is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 34.87M$ 24.09M$ 4.35M$ 228.43K$ 71.41K
Gross Profit$ 10.67M$ 8.34M$ 1.70M$ 110.60K$ 45.56K
Operating Income$ -5.81M$ -4.79M$ -27.00M$ -2.44M$ -576.87K
EBITDA$ -5.15M$ -3.82M$ -26.45M$ -12.10M$ -2.60M
Net Income$ -5.13M$ -4.51M$ -26.74M$ -12.44M$ -2.78M
Balance Sheet
Cash & Short-Term Investments$ 9.69M$ 16.29M$ 21.83M$ 2.05M$ 997.48K
Total Assets$ 30.56M$ 27.35M$ 29.55M$ 2.20M$ 1.05M
Total Debt$ 952.48K$ 657.71K$ 765.26K$ 1.90M$ 1.91M
Net Debt$ -8.73M$ -15.63M$ -21.06M$ -145.17K$ 923.23K
Total Liabilities$ 7.06M$ 6.14M$ 7.92M$ 1.99M$ 2.00M
Stockholders' Equity$ 23.50M$ 21.21M$ 21.63M$ 211.66K$ -954.84K
Cash Flow
Free Cash Flow$ -14.85M$ -9.56M$ -5.55M$ -1.83M$ -658.49K
Operating Cash Flow$ -12.53M$ -8.78M$ -5.25M$ -1.83M$ -657.30K
Investing Cash Flow$ -2.32M$ -656.15K$ -14.62M$ 0.00$ -1.19K
Financing Cash Flow$ 9.29M$ 3.43M$ 39.47M$ 2.90M$ 1.61M
Currency in USD

Sunshine Biopharma Earnings and Revenue History

Sunshine Biopharma Debt to Assets

Sunshine Biopharma Cash Flow

Sunshine Biopharma Forecast EPS vs Actual EPS